Beriberi natural history, complications and prognosis: Difference between revisions

	Beriberi Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Beriberi from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Beriberi natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Beriberi natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Beriberi natural history, complications and prognosis
CDC on Beriberi natural history, complications and prognosis
Beriberi natural history, complications and prognosis in the news
Blogs on Beriberi natural history, complications and prognosis
Directions to Hospitals Treating Beriberi
Risk calculators and risk factors for Beriberi natural history, complications and prognosis

Revision as of 15:42, 8 November 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Abdelrahman Ibrahim Abushouk, MD [2]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

In infants born to thiamine-deficient mothers, the symptoms may start as early as one month of age.
The hepatic stores of thiamine last for only 18 days. Lack or deficient consumption leads to gradual appearance of manifestations.
If left untreated, patients with beriberi may progress to develop heart failure, limb paresis, and delirium. However, thiamine treatment is highly effective and leads to rapid improvements.

Common complications of Beriberi include:
- [Complication 1]
- [Complication 2]
- [Complication 3]

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
[Subtype of disease/malignancy] is associated with the most favorable prognosis.
The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

@@ Line 11: / Line 11: @@
 === Natural History ===
-* The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
+* In infants born to thiamine-deficient mothers, the symptoms may start as early as one month of age.
-* The symptoms of (disease name) typically develop ___ years after exposure to ___.
+* The hepatic stores of thiamine last for only 18 days. Lack or deficient consumption leads to gradual appearance of manifestations.
-* If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
+* If left untreated, patients with beriberi may progress to develop heart failure, limb paresis, and delirium. However, thiamine treatment is highly effective and leads to rapid improvements.
 === Complications ===
-* Common complications of [disease name] include:
+* Common complications of Beriberi include:
 ** [Complication 1]
 ** [Complication 2]